Table Of Content

J. Pharm. Med. (1994) 4, 229-230 Index Al-Khamees HA see Al-Rashood KA and benzarone in human plasma Al-Khamis KI see Al-Rashood KA by high-performance liquid Al-Rashood KA, Al-Khamees HA, AI- chromatography, 127 Khamis KI, Mian MS & El-Obeid Houston A see Mengel HB HA. Inhibition of clobazam and 4’- Jagroop IA see Thompson CS hydroxyclobazam metabolism by Janssens M see Purello F desmethylclobazam and Lehmacher W see Diebschlag W carbamazepine-10,11-epoxide using McCaffrey PM see Tham TCK rabbit liver microsomes, 165 Malcolm AD & Darley-Usmar V. Anti- Armstrong NA see Tansey IP atherosclerotic and lipid-modifying Arnold K. Pills and Profits: An historical drugs in the 1990s, 41 exhibition at the Wellcome Mason U. Multiple sclerosis: recent Institute, 151 advances in therapy reviewed, 191 Asscher, Sir William, Improving the Mengel HB, Houston A & Back DJ. An safety of medicines and medicine. evaluation of the interaction Wellcome Lecture on between tiagabine and oral pharmaceutical medicine delivered contraceptives in female at the Apothecaries Hall, London, volunteers, 141 26 April 1994, 105 Mian MS see Al-Rashood KA Back DJ see Mengel HB Mikhailidis DP see Thompson CS Bradbury WH see Thompson CS Moretto C see Galzigna L Brubacher D. Aspects of compliance: a Nocker W see Diebschlag W review, 31 Pelat P see Thompson CS Bruno G see Galzigna L Przyborowski L see Gumieniczek A Chevallier P see Purello F Pullman WE. Suggestions on how a Coppen A. Management of depressive working party might be run. illness, 135 Experience gained from The Darley-Usmar V see Malcolm AD Society of Pharmaceutical Diebschlag W, Nocker W, Lehmacher W Medicine Asthma Working Party & Rehn D. A clinical comparison Expert Panel, 101 of two doses of O-(B- Purello D’Ambrosio F, Tigano F, Gallesio Hydroxyethyl)-rutosides MT, Chevallier P & Janssens M. (oxerutins) in patients with chronic Astemizole-D compared with venous insufficiency, 7 tripolidine-D (Actifed®) for acute Dupin-Spriet T & Spriet A. Women in treatment of perennial allergic clinical trials, 207 rhinitis, 15 Dupin-Spriet T see Spriet A Rees L. The use of recombinant human El-Obeid HA see Al-Rashood KA erythropoietin in children with Gallesio MT see Purello F renal disease, 65 Galzigna L, Rizzoli V, Schiappelli MP, Rehn D see Diebschlag W Moretto C & Bruno G. MR 889: A Riddell JG see Tham TCK synthetic inhibitor of some lung Rizzoli V see Galzigna L enzymes, 23 Schiappelli MP see Galzigna L Gumieniczek A & Przyborowski L. Silke B see Tham TCK Determination of benzbromarone Spriet A & Dupin-Spriet T. Allocation to 229 230 Index treatment groups in randomized Thompson CS, Jagroop IA, Bradbury open trials, 1 WH, Pelat P & Mikhailidis DP. Spriet A see Dupin-Spriet T Beneficial effect of buflomedil on Tansey IP, Armstrong NA & Walker SR. microalbuminuria in long-term Trends in pharmaceutical diabetic rats, 179 innovation. The introduction of Thompson KA see Walker BR products on to the UK market, Tigano F see Purello F 1960-1989, 85 Walker BR & Thompson KA. Health care Tham TCK, McCaffrey PM, Whitehead reform—new imperatives for EM, Silke B & Riddell JG. pharmaceutical product Reproducibility of forearm blood development, 79 flow measurements in healthy Walker SR see Tansey IP volunteers using computer-assisted Whitehead EM see Tham TCK strain gauge venous occlusion plethysmography, 173